Loading...

Hiroki Nakaoka, PhD

Title(s)Postdoctoral Scholar, Radiation Oncology
SchoolSchool of Medicine
AddressLocation Required
Varies CA 00000
Phone--
Emailhiroki.nakaoka@ucsf.edu
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    The University of Tokyo, JAPANPh.D06/2016Division of Molecular Pathology

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Defining the ATPome reveals cross-optimization of metabolic pathways. Nat Commun. 2020 08 28; 11(1):4319. Bennett NK, Nguyen MK, Darch MA, Nakaoka HJ, Cousineau D, Ten Hoeve J, Graeber TG, Schuelke M, Maltepe E, Kampmann M, Mendelsohn BA, Nakamura JL, Nakamura K. PMID: 32859923.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Nf1 mutant tumors undergo transcriptome and kinome re-modeling after inhibition of either mTOR or MEK. Mol Cancer Ther. 2020 Aug 26. Pucciarelli D, Angus SP, Huang B, Zhang C, Nakaoka HJ, Krishnamurthi G, Bandyopadhyay S, Clapp DW, Shannon K, Johnson GL, Nakamura JL. PMID: 32847978.
      View in: PubMed   Mentions:    Fields:    
    3. Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction. Mol Cell. 2018 10 18; 72(2):328-340.e8. Han H, Qi R, Zhou JJ, Ta AP, Yang B, Nakaoka HJ, Seo G, Guan KL, Luo R, Wang W. PMID: 30293781.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    4. Hippo signaling dysfunction induces cancer cell addiction to YAP. Oncogene. 2018 12; 37(50):6414-6424. Han H, Yang B, Nakaoka HJ, Yang J, Zhao Y, Le Nguyen K, Bishara AT, Mandalia TK, Wang W. PMID: 30068939.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    5. Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin a5ß1 and tumour growth. Oncogenesis. 2017 May 15; 6(5):e334. Nakaoka HJ, Tanei Z, Hara T, Weng JS, Kanamori A, Hayashi T, Sato H, Orimo A, Otsuji K, Tada K, Morikawa T, Sasaki T, Fukayama M, Seiki M, Murakami Y, Sakamoto T. PMID: 28504692.
      View in: PubMed   Mentions:
    6. Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes. Proc Natl Acad Sci U S A. 2017 05 30; 114(22):E4416-E4424. Hara T, Nakaoka HJ, Hayashi T, Mimura K, Hoshino D, Inoue M, Nagamura F, Murakami Y, Seiki M, Sakamoto T. PMID: 28507122.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    7. Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus. Sci Rep. 2016 11 24; 6:37815. Uematsu T, Fujita T, Nakaoka HJ, Hara T, Kobayashi N, Murakami Y, Seiki M, Sakamoto T. PMID: 27883071.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    8. Loss of YAP1 defines neuroendocrine differentiation of lung tumors. Cancer Sci. 2016 Oct; 107(10):1527-1538. Ito T, Matsubara D, Tanaka I, Makiya K, Tanei ZI, Kumagai Y, Shiu SJ, Nakaoka HJ, Ishikawa S, Isagawa T, Morikawa T, Shinozaki-Ushiku A, Goto Y, Nakano T, Tsuchiya T, Tsubochi H, Komura D, Aburatani H, Dobashi Y, Nakajima J, Endo S, Fukayama M, Sekido Y, Niki T, Murakami Y. PMID: 27418196.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    9. The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux. Cell Discov. 2016; 2:16019. Yoshino S, Hara T, Nakaoka HJ, Kanamori A, Murakami Y, Seiki M, Sakamoto T. PMID: 27462466.
      View in: PubMed   Mentions:
    10. NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells. Sci Rep. 2016 Mar 07; 6:22784. Nakaoka HJ, Hara T, Yoshino S, Kanamori A, Matsui Y, Shimamura T, Sato H, Murakami Y, Seiki M, Sakamoto T. PMID: 26948053.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    Hiroki's Networks
    Concepts (67)
    Derived automatically from this person's publications.
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _